Pre-Market Review: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc. Editor Note: For more information about this release, please scroll to bottom. PR Newswire LONDON, October 18, 2013 LONDON, October 18, 2013 /PRNewswire/ -- On Thursday, October 17, 2013, the S&P 500 ended the day at 1,733.15, up 0.67%; the Dow Jones Industrial Average closed at 15,371.65, down 0.01%; while the NASDAQ Composite finished at 3,863.15, up 0.62%. Shares in the medical appliances and equipment industry mostly ended on a higher note, even as the broader market fluctuated between gains and losses. The major movers in the industry included Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM). AAAResearchReports.com initiated preliminary technical research on BSX, ABT, ZMH, and ETRM. These free reports are accessible by signing today at: http://www.aaaresearchreports.com/register/ On Thursday, shares in Boston Scientific Corp. ended the day at the previous day's closing price of $12.38, after hitting a new 52-week high of $12.48. A total of 12.41 million shares were traded, which is below the daily average volume of 15.34 million. The company's shares have gained 4.03% in the last one month and 29.77% in the previous three months, outperforming the S&P 500 which has gained 1.67% and 3.11% during the respective periods. Furthermore, Boston Scientific Corp.'s stock is trading above its 50-day and 200-day moving averages of $11.48 and $9.03, respectively. The free technical analysis on BSX is available by signing up at: www.AAAResearchReports.com/BSX101813.pdf Abbott Laboratories' stock surged on Thursday, extending the gains from the previous trading session. The company's shares closed the day 3.54% higher at $37.17, after oscillating between $35.89 and $37.27. A total of 17.35 million shares were traded, which is significantly above the daily average volume of 7.47 million. The company's shares have surged 9.32% in the previous three trading sessions and 6.29% in the last one month, outperforming the S&P 500 which has gained 1.35% and 1.67% during the respective periods. Additionally, Abbott Laboratories' stock is trading above its 50-day and 200-day moving averages of $34.38 and $35.15, respectively. Register now to download free research on ABT at: www.AAAResearchReports.com/ABT101813.pdf On Thursday, Zimmer Holdings Inc.'s stock closed at $87.88, up 0.18% from the previous day's closing price of $87.72. The company's shares vacillated between $87.19 and $87.95 during the trading session. A total of 0.84 million shares were traded, which is below the daily average volume of 1.03 million. The company's shares have gained 5.69% in the last one month and 7.59% in the previous three months, compared to a gain of 1.67% and 3.11% in the S&P 500 during the respective periods. Moreover, Zimmer Holdings Inc.'s stock is trading near its 52-week high of $88.19 and above its 50-day and 200-day moving averages of $82.02 and $77.81, respectively. A free report on ZMH can be accessed by registering at: www.AAAResearchReports.com/ZMH101813.pdf EnteroMedics Inc.'s stock plummeted on Thursday, reversing all the gains from the previous trading session. The company's shares ended the day 2.61% lower at $1.49, after fluctuating between $1.47 and $1.56. A total of 0.99 million shares were traded, which is below the daily average volume of 1.04 million. Despite Thursday's losses, ANN INC.'s stock has surged 19.20% in the last one month and 41.90% in the previous three months, outperforming the S&P 500 which has gained 1.67% and 3.11% during the respective periods. Further, EnteroMedics Inc.'s stock is trading above its 50-day and 200-day moving averages of $1.17 and $1.28, respectively. Register with AAAResearchReports.com and download research on ETRM for free at: www.AAAResearchReports.com/ETRM101813.pdf ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. SOURCE AAA Research Reports Contact: Peter F. Jones; + 1 (646) 396-9126 (North America); firstname.lastname@example.org
Pre-Market Review: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc.